These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1899177)

  • 41. Kinetic mechanism of the activation of human plasminogen by streptokinase.
    Kosow DP
    Biochemistry; 1975 Oct; 14(20):4459-65. PubMed ID: 126078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of Lys-698-to-Met substitution in human plasminogen catalytic domain.
    Terzyan S; Wakeham N; Zhai P; Rodgers K; Zhang XC
    Proteins; 2004 Aug; 56(2):277-84. PubMed ID: 15211511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of an extremely large, ligand-induced conformational change in plasminogen.
    Mangel WF; Lin BH; Ramakrishnan V
    Science; 1990 Apr; 248(4951):69-73. PubMed ID: 2108500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the plasminogen activator activity units of urinary-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA).
    Creighton-Kempsford LJ; Pring JB; Gaffney PJ
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):481-3. PubMed ID: 1420825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The activation mechanism of human plasminogen.
    Rickli EE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
    [No Abstract]   [Full Text] [Related]  

  • 47. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.
    Cockell CS; Marshall JM; Dawson KM; Cederholm-Williams SA; Ponting CP
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):99-105. PubMed ID: 9639568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of divalent metal cations on the inhibition of human coagulation factor Xa by plasma proteinase inhibitors.
    Ellis V; Scully M; Kakkar V
    Biochim Biophys Acta; 1983 Sep; 747(1-2):123-9. PubMed ID: 6192845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM; Conrad HE; Pizzo SV
    Biochemistry; 1991 Nov; 30(45):10999-1003. PubMed ID: 1932024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prion protein stimulates tissue-type plasminogen activator-mediated plasmin generation via a lysine-binding site on kringle 2.
    Epple G; Schleuning WD; Kettelgerdes G; Kottgen E; Gessner R; Praus M
    J Thromb Haemost; 2004 Jun; 2(6):962-8. PubMed ID: 15140132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo.
    Kawao N; Nagai N; Tamura Y; Horiuchi Y; Okumoto K; Okada K; Suzuki Y; Umemura K; Yano M; Ueshima S; Kaji H; Matsuo O
    Thromb Haemost; 2012 Apr; 107(4):749-59. PubMed ID: 22318286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase.
    Namiranian S; Naito Y; Kakkar VV; Scully MF
    Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):977-82. PubMed ID: 7639718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 6-aminohexanoate and chloride ion in the activation by urokinase of porcine plasminogens.
    Machovich R; Owen WG
    Biochim Biophys Acta; 1990 Aug; 1040(1):109-11. PubMed ID: 2378895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 59. Enhancement of reciprocal activation of prourokinase and plasminogen by the bacterial lipopeptide surfactins and iturin Cs.
    Kikuchi T; Hasumi K
    J Antibiot (Tokyo); 2003 Jan; 56(1):34-7. PubMed ID: 12670048
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of some properties of native (Glu) and modified (Lys) human plasminogen.
    Markus G; Evers JL; Hobika GH
    J Biol Chem; 1978 Feb; 253(3):733-9. PubMed ID: 621201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.